Skip to main content

Table 1 Net inhibitory effect of thrombin, PAR-1 and PAR1-AP on human umbilical artery tone.

From: Effects of thrombin, PAR-1 activating peptide and a PAR-1 antagonist on umbilical artery resistance in vitro

Thrombin (n = 6)

(% ± SEM)

PAR1-AP (n = 6)

(% ± SEM)

PAR-1 Antagonist (n = 6)

(% ± SEM)

(P Value)

0.5 U/ml

#28.90 ± 2.60

10 -9 M

*23.91 ± 5.64

10 -9 M

2.83 ± 3.05 (NS)

(0.630)

1 U/ml

*35.39 ± 3.91

10 -8 M

*37.32 ± 2.29

10 -8 M

3.80 ± 2.33 (NS)

(0.471)

2 U/ml

*44.72 ± 2.31

10 -7 M

*52.39 ± 1.28

10 -7 M

5.60 ± 3.74 (NS)

(0.228)

3 U/ml

*53.51 ± 4.62

10 -6 M

*61.50 ± 1.43

10 -6 M

7.03 ± 5.74 (NS)

(0.148)

    

10 -5 M

6.87 ± 4.48 (NS)

(0.815)

  1. Values presented represent the mean inhibitory effects on umbilical artery tone i.e. after adjusting for control / vehicle experiments. The values provided represent % inhibition ± standard error of the mean (SEM). The PAR1-AP used was Threonine-Phenylalanine-Leucine-leucine-Arginine-NH2. The PAR-1 antagonist used was Ser- pFPhe-pGPe-Leu-Arg-Orn-NH2. The values were compared with amplitude measurements observed prior to drug addition (NS not significant, # P < 0.01, * P < 0.001).